Designer Nucleases: Gene-Editing Therapies using CCR5 as an Emerging Target in HIV

Volume: 17, Issue: 5, Pages: 306 - 323
Published: Dec 4, 2019
Abstract
Acquired Immunodeficiency Syndrome (AIDS), caused by the Human Immunodeficiency Virus (HIV), is a life-threatening disorder that persists worldwide as a severe health problem. Since it was linked with the HIV attachment process, the Chemokine receptor, CCR5, has been at the development leading edge of several gene-based therapies. Given the shortcomings of the current antiretroviral treatment procedure and the non-availability of a licensed...
Paper Details
Title
Designer Nucleases: Gene-Editing Therapies using CCR5 as an Emerging Target in HIV
Published Date
Dec 4, 2019
Volume
17
Issue
5
Pages
306 - 323
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.